Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380080861> ?p ?o ?g. }
- W4380080861 endingPage "e33904" @default.
- W4380080861 startingPage "e33904" @default.
- W4380080861 abstract "Background: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers (ARBs) have been hypothesized to benefit patients with COVID-19 via the inhibition of viral entry and other mechanisms. We conducted an individual participant data (IPD) meta-analysis assessing the effect of starting the ARB losartan in recently hospitalized COVID-19 patients. Methods: We searched ClinicalTrials.gov in January 2021 for U.S./Canada-based trials where an angiotensin-converting enzyme inhibitors/ARB was a treatment arm, targeted outcomes could be extrapolated, and data sharing was allowed. Our primary outcome was a 7-point COVID-19 ordinal score measured 13 to 16 days post-enrollment. We analyzed data by fitting multilevel Bayesian ordinal regression models and standardizing the resulting predictions. Results: 325 participants (156 losartan vs 169 control) from 4 studies contributed IPD. Three were randomized trials; one used non-randomized concurrent and historical controls. Baseline covariates were reasonably balanced for the randomized trials. All studies evaluated losartan. We found equivocal evidence of a difference in ordinal scores 13-16 days post-enrollment (model-standardized odds ratio [OR] 1.10, 95% credible interval [CrI] 0.76–1.71; adjusted OR 1.15, 95% CrI 0.15–3.59) and no compelling evidence of treatment effect heterogeneity among prespecified subgroups. Losartan had worse effects for those taking corticosteroids at baseline after adjusting for covariates (ratio of adjusted ORs 0.29, 95% CrI 0.08–0.99). Hypotension serious adverse event rates were numerically higher with losartan. Conclusions: In this IPD meta-analysis of hospitalized COVID-19 patients, we found no convincing evidence for the benefit of losartan versus control treatment, but a higher rate of hypotension adverse events with losartan." @default.
- W4380080861 created "2023-06-10" @default.
- W4380080861 creator A5016680276 @default.
- W4380080861 creator A5018053654 @default.
- W4380080861 creator A5020479008 @default.
- W4380080861 creator A5022728582 @default.
- W4380080861 creator A5028193922 @default.
- W4380080861 creator A5031849167 @default.
- W4380080861 creator A5037019183 @default.
- W4380080861 creator A5037409342 @default.
- W4380080861 creator A5040619239 @default.
- W4380080861 creator A5043647925 @default.
- W4380080861 creator A5047523143 @default.
- W4380080861 creator A5057261158 @default.
- W4380080861 creator A5057646389 @default.
- W4380080861 creator A5070225296 @default.
- W4380080861 creator A5070880383 @default.
- W4380080861 creator A5072760500 @default.
- W4380080861 creator A5089154408 @default.
- W4380080861 creator A5089323805 @default.
- W4380080861 date "2023-06-09" @default.
- W4380080861 modified "2023-09-27" @default.
- W4380080861 title "Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis" @default.
- W4380080861 cites W2091671824 @default.
- W4380080861 cites W2203714058 @default.
- W4380080861 cites W2531269403 @default.
- W4380080861 cites W2749069611 @default.
- W4380080861 cites W2970684805 @default.
- W4380080861 cites W3013717035 @default.
- W4380080861 cites W3016572296 @default.
- W4380080861 cites W3017545174 @default.
- W4380080861 cites W3019906742 @default.
- W4380080861 cites W3021992825 @default.
- W4380080861 cites W3023640683 @default.
- W4380080861 cites W3023751598 @default.
- W4380080861 cites W3027630905 @default.
- W4380080861 cites W3029584987 @default.
- W4380080861 cites W3030177929 @default.
- W4380080861 cites W3034858522 @default.
- W4380080861 cites W3035819488 @default.
- W4380080861 cites W3118396415 @default.
- W4380080861 cites W3122900688 @default.
- W4380080861 cites W3129370921 @default.
- W4380080861 cites W3160152911 @default.
- W4380080861 cites W3171645706 @default.
- W4380080861 cites W3175301529 @default.
- W4380080861 cites W4200049484 @default.
- W4380080861 cites W4220769600 @default.
- W4380080861 cites W4286253310 @default.
- W4380080861 cites W4293171339 @default.
- W4380080861 cites W4297991882 @default.
- W4380080861 doi "https://doi.org/10.1097/md.0000000000033904" @default.
- W4380080861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37335665" @default.
- W4380080861 hasPublicationYear "2023" @default.
- W4380080861 type Work @default.
- W4380080861 citedByCount "0" @default.
- W4380080861 crossrefType "journal-article" @default.
- W4380080861 hasAuthorship W4380080861A5016680276 @default.
- W4380080861 hasAuthorship W4380080861A5018053654 @default.
- W4380080861 hasAuthorship W4380080861A5020479008 @default.
- W4380080861 hasAuthorship W4380080861A5022728582 @default.
- W4380080861 hasAuthorship W4380080861A5028193922 @default.
- W4380080861 hasAuthorship W4380080861A5031849167 @default.
- W4380080861 hasAuthorship W4380080861A5037019183 @default.
- W4380080861 hasAuthorship W4380080861A5037409342 @default.
- W4380080861 hasAuthorship W4380080861A5040619239 @default.
- W4380080861 hasAuthorship W4380080861A5043647925 @default.
- W4380080861 hasAuthorship W4380080861A5047523143 @default.
- W4380080861 hasAuthorship W4380080861A5057261158 @default.
- W4380080861 hasAuthorship W4380080861A5057646389 @default.
- W4380080861 hasAuthorship W4380080861A5070225296 @default.
- W4380080861 hasAuthorship W4380080861A5070880383 @default.
- W4380080861 hasAuthorship W4380080861A5072760500 @default.
- W4380080861 hasAuthorship W4380080861A5089154408 @default.
- W4380080861 hasAuthorship W4380080861A5089323805 @default.
- W4380080861 hasBestOaLocation W43800808611 @default.
- W4380080861 hasConcept C105795698 @default.
- W4380080861 hasConcept C119043178 @default.
- W4380080861 hasConcept C121117317 @default.
- W4380080861 hasConcept C126322002 @default.
- W4380080861 hasConcept C156957248 @default.
- W4380080861 hasConcept C168563851 @default.
- W4380080861 hasConcept C187960798 @default.
- W4380080861 hasConcept C197934379 @default.
- W4380080861 hasConcept C2780288358 @default.
- W4380080861 hasConcept C2908929049 @default.
- W4380080861 hasConcept C33923547 @default.
- W4380080861 hasConcept C44249647 @default.
- W4380080861 hasConcept C71924100 @default.
- W4380080861 hasConcept C84393581 @default.
- W4380080861 hasConcept C95190672 @default.
- W4380080861 hasConceptScore W4380080861C105795698 @default.
- W4380080861 hasConceptScore W4380080861C119043178 @default.
- W4380080861 hasConceptScore W4380080861C121117317 @default.
- W4380080861 hasConceptScore W4380080861C126322002 @default.
- W4380080861 hasConceptScore W4380080861C156957248 @default.
- W4380080861 hasConceptScore W4380080861C168563851 @default.
- W4380080861 hasConceptScore W4380080861C187960798 @default.